Supply Chain

Manufacture Vaccines

The Shadow of COVID-19

11/28/2023 | Stephanie Vine | 10 min read

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Discovery & Development Ingredients

Manufacturers Urged to Take Steps to Avoid DEG and EG Contamination

11/02/2023 | Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

09/22/2023 | Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

Business & Regulation Digital Technologies

Video: Matthew Lakelin on Improving Supply Chain Efficiency

03/13/2023 | Rob Coker

A video interview covering supply chain improvement technology

Business & Regulation Business Practice

A Roadmap to Greener Pharma Logistics

02/27/2023 | Julius Graf von Pfeil, Kees Schmidt | 10 min read

How to make the art of pharmaceutical logistics more sustainable.

Business & Regulation Trends & Forecasts

Video Roundtable: Cell & Gene in a World in Turmoil

12/13/2022 | Angus Stewart

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

Manufacture Contract Manufacturing Services

eBook: What’s Hot in Outsourcing & Supply Chains?

12/08/2022 | 3 min read

This free eBook showcases some of our top content covering outsourcing and supply chains.

Business & Regulation Trends & Forecasts

Constructing 2022: How Alive Are the Life Sciences?

12/08/2022 | Angus Stewart | 3 min read

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

11/30/2022 | Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Business & Regulation Standards & Regulation

Why Only a Collective Approach Can Beat Fake Medicine

11/01/2022 | Géraldine Lissalde-Bonnet | 5 min read

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

1
2
3
4
5
...

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine